John N. Hendrick has nearly three decades of executive experience, building both early stage medical device companies as well as large divisions in Medical device Corporations. During his tenure, Mr. Hendrick has participated in the development, manufacture and sales of products in the field of Cardiology, Urology, Orthopedics and Ophthalmology. Currently he is CEO of NeoVista Inc. a company in the field of Age Related Macular Degeneration. Prior to his accepting the role of CEO with Neovista, he was the EVP and General Manger of the Medical Division of Sanmina-Sci, a $12 billion dollar contract manufacturing corporation. Mr. Hendrick was the first employee of the Medical Division that over a two year period grew sales from $200 million to over $600 million, creating the largest medical device contract manufacturing organization in the world. Prior to Sanmina-Sci he was the COO of VidaMed Inc. a urological company for the treatment of Benign Prostate Hyperplasia. Mr. Hendrick was involved taking the company through a successful IPO which lead eventually to the acquisition of the Company by Medtronic Inc. Prior to VidaMed, Mr. Hendrick held executive positions in Allergan Medical Optics, Baxter and American Hospital Supply.
Starting a Biomedical company can be tough. There are plenty of challenges, but the one that most entrepreneurs find most daunting is raising start-up capital. Especially when the big players are making a kill in the same niche with their blockbuster products. John Hendrick, a seasoned medical device entrepreneur, will discuss various aspects of being a charismatic leader/entrepreneur in the Biomedical industry. He will walk you thru’ the creative steps and calculated risks you may have to consider taking to get your Biomedical company funded especially when the odds are pitched heavily against you. He will touch upon how to navigate the regulatory maze, enforce decisions from a indecisive and reluctant FDA. He will address questions such as when VCs talk about "market conditions," what do they mean? And….more…
